Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea
· Delayed Price · Currency is KRW 1,199.00
-11.00 (-0.91%)
At close: Jun 13, 2025, 3:30 PM KST
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 39.84 billion as of June 16, 2025. Its market cap has decreased by -66.19% in one year.
Market Cap
39.84B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
194.86
Stock Price
1,199.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 39.84B, a decrease of -90.83%. That is a compound annual growth rate of -37.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 39.67B | -55.59% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | 472.24B | 8.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 381.06T |
| SK hynix | 162.58T |
| Samsung Biologics | 72.53T |
| LG Energy Solution | 69.26T |
| Hanwha Aerospace | 44.59T |
| Hyundai Motor Company | 43.49T |
| HD Hyundai Heavy Industries | 37.95T |
| Kia Corporation | 37.89T |